Hc Advisors, LLC Dyne Therapeutics, Inc. Transaction History

Hc Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$7.2 - $15.17 $8,316 - $17,521	-1,155 Reduced 7.49%	14,272 $181,000
Q2 2022 Aug 08, 2022	SELL	$4.36 - $10.5 $436 - $1,050	-100 Reduced 0.64%	15,427 $106,000
Q1 2022 May 06, 2022	SELL	$6.52 - $12.27 $21,235 - $39,963	-3,257 Reduced 17.34%	15,527 $150,000
Q4 2021 Feb 02, 2022	BUY	$11.89 - $16.07 $223,341 - $301,858	18,784 New	18,784 $223,000

207

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $731M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hc Advisors, LLC with notifications on news.